Advertisement
Propensity-matched analysis shows safety edge over transvenous devices
First study of arrhythmia prevalence and treatment in this setting
Interim analysis from a second major trial shows success
Efficacy and safety end points met in 90 percent of patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement